ID   11060
AC   CVCL_C9CM
SY   NMC 11060
DR   Wikidata; Q123030209
RX   PubMed=20871596;
RX   PubMed=29348827;
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT (PubMed=20871596).
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   29Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   PubMed=20871596; DOI=10.1038/nature09504; PMCID=PMC3010259;
RA   Filippakopoulos P., Qi J., Picaud S., Shen Y., Smith W.B., Fedorov O.,
RA   Morse E.M., Keates T., Hickman T.T., Felletar I., Philpott M.,
RA   Munro S., McKeown M.R., Wang Y.-C., Christie A.L., West N.H., Cameron M.J.,
RA   Schwartz B.E., Heightman T.D., La Thangue N.B., French C.A., Wiest O.,
RA   Kung A.L.-J., Knapp S., Bradner J.E.;
RT   "Selective inhibition of BET bromodomains.";
RL   Nature 468:1067-1073(2010).
//
RX   PubMed=29348827; DOI=10.18632/oncotarget.22862; PMCID=PMC5762512;
RA   Stirnweiss A., Oommen J., Kotecha R.S., Kees U.R., Beesley A.H.;
RT   "Molecular-genetic profiling and high-throughput in vitro drug
RT   screening in NUT midline carcinoma-an aggressive and fatal disease.";
RL   Oncotarget 8:112313-112329(2017).
//